Steris (STE) Other Non-Current Liabilities (2018 - 2026)
Steris' (STE) quarterly Other Non-Current Liabilities came in at $71.7 million in Q1 2026, up 15.83% year-on-year from $61.9 million in Q1 2025, and up 6.38% quarter-over-quarter from $67.4 million in Q4 2025.
Steris (STE) Other Non-Current Liabilities (2018 - 2026) Analysis & Trends
Steris' Other Non-Current Liabilities history runs 9 years deep, the most recent figure standing at $71.7 million for Q1 2026.
- On a quarterly basis, Other Non-Current Liabilities rose 15.83% year-over-year to $71.7 million in Q1 2026; TTM through Mar 2026 was $71.7 million, a 15.83% increase from a year earlier, with the FY2026 full-year figure at $71.7 million, up 15.83% from the prior year.
- Other Non-Current Liabilities improved to $71.7 million in Q1 2026 per STE's latest filing, from $67.4 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $78.4 million in Q4 2023 and bottomed at $61.9 million in Q1 2025.
- The 5-year median for Other Non-Current Liabilities is $73.1 million (2022), against an average of $72.0 million.
- Across the five-year window, Other Non-Current Liabilities dropped 15.07% in 2022 and climbed 15.83% in 2026, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $72.7 million in 2022, then grew by 7.76% to $78.4 million in 2023, then slipped by 6.71% to $73.1 million in 2024, then declined by 7.83% to $67.4 million in 2025, then grew by 6.38% to $71.7 million in 2026.
- Per Business Quant, the three latest STE Other Non-Current Liabilities figures stand at $71.7 million (Q1 2026), $67.4 million (Q4 2025), and $63.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 71.70 Mn |
| Dec 31, 2025 | 67.40 Mn |
| Sep 30, 2025 | 63.90 Mn |
| Jun 30, 2025 | 63.60 Mn |
| Mar 31, 2025 | 61.90 Mn |
| Dec 31, 2024 | 73.13 Mn |
| Sep 30, 2024 | 74.15 Mn |
| Jun 30, 2024 | 72.37 Mn |
| Mar 31, 2024 | 71.55 Mn |
| Dec 31, 2023 | 78.39 Mn |
| Sep 30, 2023 | 76.55 Mn |
| Jun 30, 2023 | 76.60 Mn |
| Mar 31, 2023 | 76.14 Mn |
| Dec 31, 2022 | 72.75 Mn |
| Sep 30, 2022 | 75.90 Mn |
| Jun 30, 2022 | 73.08 Mn |
| Mar 31, 2022 | 75.58 Mn |
| Dec 31, 2021 | 74.76 Mn |
| Sep 30, 2021 | 83.59 Mn |
| Jun 30, 2021 | 86.04 Mn |